Showing results (731-740 of 832) with videos related to

Sort By:
Pageof 84
Obstetrics and Gynecology|February 27, 2025
Long-Term Changes to Cardiovascular Biomarkers After Hormone Therapy in the Women's Health Initiative Hormone Therapy Clinical TrialsMatthew Nudy, Aaron K Aragaki, Xuezhi Jiang, et al.
Menopause (New York, N.Y.)|September 19, 2013
Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational StudyChrisandra L Shufelt, C Noel Bairey Merz, Ross L Prentice, et al.
JAMA|March 6, 2008
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestinGerardo Heiss, Robert Wallace, Garnet L Anderson, et al.
Journal of Wildlife Diseases|December 18, 2018
AN INTERFERON GAMMA RELEASE ASSAY FOR THE DETECTION OF IMMUNE SENSITIZATION TO <i>MYCOBACTERIUM BOVIS</i> IN AFRICAN WILD DOGS (<i>LYCAON PICTUS</i>)Roxanne L Higgitt, O Louis van Schalkwyk, Lin-Mari deKlerk-Lorist, et al.
The American Journal of Clinical Nutrition|May 19, 2017
Low-fat dietary pattern and cardiovascular disease: results from the Women's Health Initiative randomized controlled trialRoss L Prentice, Aaron K Aragaki, Linda Van Horn, et al.
American Journal of Epidemiology|April 22, 2020
Dual-Outcome Intention-to-Treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy TrialsRoss L Prentice, Aaron K Aragaki, Rowan T Chlebowski, et al.
Pageof 84